Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma

Hepatology International

Saved in:

Bibliographic Details
Main Author:	Huynh The Hung
Other Authors:	MEDICINE
Format:	Article
Published:	Hepatology International 2022
Subjects:	Preclinical study liver cancer PDX model fibroblast growth factor signaling pathway growth inhibition drug resistance metastasis immune response overall survival vascular normalization tumor hypoxia
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/230599
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-230599
record_format	dspace
spelling	sg-nus-scholar.10635-2305992024-04-17T09:32:42Z Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma Huynh The Hung MEDICINE Preclinical study liver cancer PDX model fibroblast growth factor signaling pathway growth inhibition drug resistance metastasis immune response overall survival vascular normalization tumor hypoxia Hepatology International 15 1236–1246 2022-08-29T03:17:10Z 2022-08-29T03:17:10Z 2021-07-31 Article Huynh The Hung (2021-07-31). Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma. Hepatology International 15 : 1236–1246. ScholarBank@NUS Repository. 1936-0533 1936-0541 https://scholarbank.nus.edu.sg/handle/10635/230599 Hepatology International
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Preclinical study liver cancer PDX model fibroblast growth factor signaling pathway growth inhibition drug resistance metastasis immune response overall survival vascular normalization tumor hypoxia
spellingShingle	Preclinical study liver cancer PDX model fibroblast growth factor signaling pathway growth inhibition drug resistance metastasis immune response overall survival vascular normalization tumor hypoxia Huynh The Hung Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
description	Hepatology International
author2	MEDICINE
author_facet	MEDICINE Huynh The Hung
format	Article
author	Huynh The Hung
author_sort	Huynh The Hung
title	Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
title_short	Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
title_full	Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
title_fullStr	Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
title_full_unstemmed	Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
title_sort	targeted inhibition of fgf19/fgfr cascade improves anti-tumor immunity and response rate in hepatocellular carcinoma
publisher	Hepatology International
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/230599
_version_	1800915558838829056

Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma

Similar Items